A drug repurposing approach reveals targetable epigenetic pathways in Plasmodium vivax hypnozoites.
Maher SP, Bakowski MA, Vantaux A, Flannery EL, Andolina C, Gupta M, Antonova-Koch Y, Argomaniz M, Cabrera-Mora M, Campo B, Chao AT, Chatterjee AK, Cheng WT, Chuenchob V, Cooper CA, Cottier K, Galinski MR, Harupa-Chung A, Ji H, Joseph SB, Lenz T, Lonardi S, Matheson J, Mikolajczak SA, Moeller T, Orban A, Padín-Irizarry V, Pan K, Péneau J, Prudhomme J, Roesch C, Ruberto A, Sabnis SS, Saney CL, Sattabongkot J, Sereshki S, Suriyakan S, Ubalee R, Wang Y, Wasisakun P, Yin J, Popovici J, McNamara CW, Joyner C, Nosten FH, Witkowski B, Le Roch KG, Kyle DE.
Maher SP, et al. Among authors: ruberto a.
Elife. 2025 Sep 30;13:RP98221. doi: 10.7554/eLife.98221.
Elife. 2025.
PMID: 41025349
Free PMC article.